Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study

Eugen Trinka; Elinor Ben-Menachem; Pedro A. Kowacs; Christian Elger; Birgit Keller; Kurt Löffler; José Francisco Rocha; Patrício Soares-da-Silva

doi:10.1111/epi.13993

Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study

Epilepsia ◽

10.1111/epi.13993 ◽

2018 ◽

Vol 59 (2) ◽

pp. 479-491 ◽

Cited By ~ 37

Author(s):

Eugen Trinka ◽

Elinor Ben-Menachem ◽

Pedro A. Kowacs ◽

Christian Elger ◽

Birgit Keller ◽

...

Keyword(s):

Controlled Release ◽

Multicenter Study ◽

Phase Iii ◽

Newly Diagnosed ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Parallel Group

Download Full-text

Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.10.009 ◽

2020 ◽

Vol 42 (12) ◽

pp. 2266-2279

Author(s):

Min-Kyung Lee ◽

Younghoon Jeon ◽

Sang Sik Choi ◽

Pyung Bok Lee ◽

Yong-Chul Kim ◽

...

Keyword(s):

Clinical Trial ◽

Neuropathic Pain ◽

Controlled Release ◽

Immediate Release ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Phase Iii Clinical Trial ◽

Parallel Group

Download Full-text

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Epilepsy & Behavior ◽

10.1016/j.yebeh.2020.106962 ◽

2020 ◽

Vol 105 ◽

pp. 106962 ◽

Cited By ~ 3

Author(s):

Fenella Kirkham ◽

Stéphane Auvin ◽

Joana Moreira ◽

Helena Gama ◽

Amílcar C. Falcão ◽

...

Keyword(s):

Clinical Trial ◽

Adjunctive Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase ◽

Parallel Group

Download Full-text

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study

Epilepsia ◽

10.1111/j.1528-1167.2008.01946.x ◽

2009 ◽

Vol 50 (3) ◽

pp. 454-463 ◽

Cited By ~ 164

Author(s):

Christian Elger ◽

Peter Halász ◽

Joana Maia ◽

Luis Almeida ◽

Patrício Soares-da-Silva ◽

...

Keyword(s):

Phase Iii ◽

Adjunctive Treatment ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Phase Iii Study

Download Full-text

A phase III, multinational, randomised, double-blind, placebo-controlled, parallel-group study to investigate the clinical efficacy and safety of Diapep277™ in newly diagnosed type one diabetes patients

http://isrctn.org/> ◽

10.1186/isrctn55429664 ◽

2013 ◽

Author(s):

Paolo Pozzilli

Keyword(s):

Clinical Efficacy ◽

Phase Iii ◽

Newly Diagnosed ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Parallel Group ◽

Type One Diabetes ◽

Diabetes Patients

Download Full-text

Faculty Opinions recommendation of A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020708.793482011 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Overactive Bladder ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Adrenoceptor Agonist ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020708.793480560 ◽

2013 ◽

Author(s):

Howard Goldman ◽

Alana M Murphy

Keyword(s):

Overactive Bladder ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Adrenoceptor Agonist ◽

Parallel Group

Download Full-text

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Randomised Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Parallel Group

Download Full-text

Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies

European Journal of Dermatology ◽

10.1684/ejd.2014.2293 ◽

2014 ◽

Vol 24 (2) ◽

pp. 201-209 ◽

Cited By ~ 17

Author(s):

Brigitte Dréno ◽

Vincenzo Bettoli ◽

Falk Ochsendorf ◽

Alison M. Layton ◽

Montserrat Perez ◽

...

Keyword(s):

Acne Vulgaris ◽

Pooled Analysis ◽

Phase Iii ◽

Efficacy And Safety ◽

Clindamycin Phosphate ◽

Double Blind ◽

Parallel Group ◽

Phase Iii Studies

Download Full-text

Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Integrated analysis of pooled data from double-blind phase III clinical studies

Epilepsia ◽

10.1111/j.1528-1167.2012.03605.x ◽

2012 ◽

Vol 54 (1) ◽

pp. 98-107 ◽

Cited By ~ 60

Author(s):

António Gil-Nagel ◽

Christian Elger ◽

Elinor Ben-Menachem ◽

Peter Halász ◽

José Lopes-Lima ◽

...

Keyword(s):

Clinical Studies ◽

Phase Iii ◽

Integrated Analysis ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Pooled Data

Download Full-text

Efficacy and safety of controlled‐release dinoprostone vaginal delivery system ( PROPESS ) in Japanese pregnant women requiring cervical ripening: Results from a multicenter, randomized, double‐blind, placebo‐controlled phase III study

Journal of Obstetrics and Gynaecology Research ◽

10.1111/jog.14472 ◽

2020 ◽

Vol 47 (1) ◽

pp. 216-225

Author(s):

Hiroaki Itoh ◽

Keisuke Ishii ◽

Naoya Shigeta ◽

Atsuo Itakura ◽

Hiromi Hamada ◽

...

Keyword(s):

Controlled Release ◽

Pregnant Women ◽

Vaginal Delivery ◽

Phase Iii ◽

Cervical Ripening ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Japanese Pregnant Women

Download Full-text